|
Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 99 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012" provides data on the Inflammatory Bowel Disease clinical trial scenario. This rep.....
Introduction GlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H1, 2012" provides data on the Inflammatory Bowel Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Bowel Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Bowel Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Inflammatory Bowel Disease 7 Report Guidance 7 Clinical Trials by Region 8 Clinical Trials by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11 Top Five Countries Contributing to Clinical Trials in Europe 12 Top Countries Contributing to Clinical Trials in North America 13 Top Countries Contributing to Clinical Trials in Middle East and Africa 14 Top Countries Contributing to Clinical Trials in Central and South America 15 Clinical Trials by BRIC Nations 16 Clinical Trials by G7 Nations 17 Clinical Trials in G7 Nations by Trial Status 18 Clinical Trials by E7 Nations 19 Clinical Trials in E7 Nations by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Unaccomplished Trials of Inflammatory Bowel Disease 24 Subjects Recruited Over a Period of Time 26 Prominent Sponsors 27 Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials 28 Prominent Drug Comparison 30 Clinical Trial Profiles 31 Clinical Trial Overview of Top Companies 31 Johnson & Johnson 31 Clinical Trial Overview of Johnson & Johnson 31 Pharmacosmos A/S 32 Clinical Trial Overview of Pharmacosmos A/S 32 Given Imaging Ltd. 33 Clinical Trial Overview of Given Imaging Ltd. 33 Pfizer Inc. 34 Clinical Trial Overview of Pfizer Inc. 34 Vifor Pharma Ltd. 35 Clinical Trial Overview of Vifor Pharma Ltd. 35 Merck & Co., Inc. 36 Clinical Trial Overview of Merck & Co., Inc. 36 GlaxoSmithKline plc 37 Clinical Trial Overview of GlaxoSmithKline plc 37 AstraZeneca PLC 38 Clinical Trial Overview of AstraZeneca PLC 38 Salix Pharmaceuticals, Ltd. 39 Clinical Trial Overview of Salix Pharmaceuticals, Ltd. 39 Abbott Laboratories 40 Clinical Trial Overview of Abbott Laboratories 40 Zealand Pharma A/S 41 Clinical Trial Overview of Zealand Pharma A/S 41 Ocera Therapeutics, Inc. 42 Clinical Trial Overview of Ocera Therapeutics, Inc. 42 Eisai Inc. 43 Clinical Trial Overview of Eisai Inc. 43 SBL Vaccines AB 44 Clinical Trial Overview of SBL Vaccines AB 44 Novogen Limited 45 Clinical Trial Overview of Novogen Limited 45 4SC AG 46 Clinical Trial Overview of 4SC AG 46 Shire Plc 47 Clinical Trial Overview of Shire Plc 47 Ranbaxy Laboratories Limited 48 Clinical Trial Overview of Ranbaxy Laboratories Limited 48 Danisco A/S 49 Clinical Trial Overview of Danisco A/S 49 Chiesi Farmaceutici SpA 50 Clinical Trial Overview of Chiesi Farmaceutici SpA 50 Clinical Trial Overview of Top Universities / Institutes / Hospitals 51 Tel-Aviv Sourasky Medical Center 51 Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 51 The National Institute of Allergy and Infectious Diseases 52 Clinical Trial Overview of the National Institute of Allergy and Infectious Diseases 52 University of Pittsburgh 53 Clinical Trial Overview of University of Pittsburgh 53 University of Alberta 54 Clinical Trial Overview of University of Alberta 54 Children's Hospital Boston 55 Clinical Trial Overview of Children's Hospital Boston 55 Indiana University 56 Clinical Trial Overview of Indiana University 56 Academic Medical Centre 57 Clinical Trial Overview of Academic Medical Centre 57 Beth Israel Deaconess Medical Center 58 Clinical Trial Overview of Beth Israel Deaconess Medical Center 58 Johns Hopkins University 59 Clinical Trial Overview of Johns Hopkins University 59 VU University Medical Center 60 Clinical Trial Overview of VU University Medical Center 60 Osaka University 61 Clinical Trial Overview of Osaka University 61 Department of Health 62 Clinical Trial Overview of Department of Health 62 University of Pennsylvania 63 Clinical Trial Overview of University of Pennsylvania 63 University Hospital, Grenoble 64 Clinical Trial Overview of University Hospital, Grenoble 64 University of California, Irvine 65 Clinical Trial Overview of University of California, Irvine 65 Vanderbilt University 66 Clinical Trial Overview of Vanderbilt University 66 Cedars-Sinai Medical Center 67 Clinical Trial Overview of Cedars-Sinai Medical Center 67 Asan Medical Center 68 Clinical Trial Overview of Asan Medical Center 68 The University of Adelaide 69 Clinical Trial Overview of The University of Adelaide 69 Tokyo Medical and Dental University 70 Clinical Trial Overview of Tokyo Medical and Dental University 70 Appendix 96 Abbreviations 96 Definitions 96 Research Methodology 97 Secondary Research 97 About GlobalData 98 Contact Us 98 Disclaimer 98 Source 99 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11 Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12 Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries, 2012* 13 Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14 Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 15 Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries, 2012* 16 Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries, 2012* 17 Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries, 2012* 19 Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Inflammatory Bowel Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24 Inflammatory Bowel Disease Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 31 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacosmos A/S, 2012* 32 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Given Imaging Ltd., 2012* 33 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vifor Pharma Ltd., 2012* 35 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 36 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 37 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 38 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Ltd., 2012* 39 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 40 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Zealand Pharma A/S, 2012* 41 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2012* 42 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 43 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by SBL Vaccines AB, 2012* 44 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novogen Limited, 2012* 45 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by 4SC AG, 2012* 46 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2012* 47 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ranbaxy Laboratories Limited, 2012* 48 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Danisco A/S, 2012* 49 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiesi Farmaceutici SpA, 2012* 50 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 51 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 52 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 53 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2012* 54 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012* 55 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2012* 56 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 57 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012* 58 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 59 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012* 60 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012* 61 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, 2012* 62 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 63 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2012* 64 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012* 65 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 66 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 67 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 68 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Adelaide, 2012* 69 Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2012* 70 List of Figures Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10 Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11 Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12 Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13 Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14 Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 15 Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16 Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries (%), 2012* 17 Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18 Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries (%), 2012* 19 Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22 Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 26 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28 Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30 GlobalData Methodology 97 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
